1-5 of 5
Tao Guan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Prospective Investigator-Initiated Phase 1/2 Study of BCMA/CD19 Dual-Targeting CAR T Therapy in Patients with Relapsed/Refractory Multiple Myeloma Including Those with Extramedullary Disease

Hua Jiang, Lu Li, Kaili Chen, Chunchen Yang, Ruixue Ma, Liangyu Xie, Can He, Fang Feng, Hao Wu, Xiaomei Chen, Dan Li, Xianghai Cai, Jin Zhao, Tao Guan, Li Ma, Min Bai, Guoxiang Wu, Liping Su, Weijun Fu
Journal: Blood
Blood (2024) 144 (Supplement 1): 923.
https://doi.org/10.1182/blood-2024-201160
Published: 2024
Journal Articles

Circulating Tumour DNA Measurements As an Early Prognostic Indicator for Newly Diagnosed Diffuse Large B-Cell Lymphoma Treated with Pola-R-CHP Regimen

Xiaolian Wen, Liping Su, Tao Guan, Jie Liu, Xuliang Shen
Journal: Blood
Blood (2024) 144 (Supplement 1): 6186.
https://doi.org/10.1182/blood-2024-206716
Published: 2024
Journal Articles

Study on the Bone Marrow Plasma Cell Percentage in Predicting Survival in Newly Diagnosed Multiple Myeloma

Tao Guan, Meijing Zheng, Liping Su
Journal: Blood
Blood (2024) 144 (Supplement 1): 6984.
https://doi.org/10.1182/blood-2024-206521
Published: 2024
Journal Articles

Identification of Piwi-Interacting RNA-32260 As a Prognostic Marker for Diffuse Large B-Cell Lymphoma

Min Zhang, Tao Guan, Liping Su
Journal: Blood
Blood (2024) 144 (Supplement 1): 6232.
https://doi.org/10.1182/blood-2024-209417
Published: 2024
Journal Articles

Clinical Observation of Camrelizumab (CAM) Combined with Bendamustine and Gemcitabine (BeGe) in Relapsed/Refractory Classical Hodgkin Lymphoma (cHL): A Phase II Trial

Min Bai, Li-Ping Su, Tao Guan
Journal: Blood
Blood (2023) 142 (Supplement 1): 4447.
https://doi.org/10.1182/blood-2023-185384
Published: 2023